ArticleFrontiers in immunology2025
Primary Sjögren's syndrome presenting with non-diffuse membranoproliferative glomerulonephritis-like lesions in cryoglobulinemic glomerulonephritis: a case report.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In primary membranoproliferative glomerulonephritis (MPGN), mesangial and capillary proliferation manifests as a diffuse, spherical change; in secondary MPGN, lesions are predominantly focal and segmental. Case presentation: A 52-year-old woman with a 2-year history of primary Sjögren's Syndrome (pSS) and no prior renal involvement developed fever, nephrotic syndrome, and acute kidney injury with oliguria after a pulmonary infection. Her highest recorded serum creatinine level was 327.3 µmol/L, and the lowest serum albumin level was 22.1 g/L. Laboratory findings included an antinuclear antibody titer of 1:320, anti-SSA/52KD antibody positivity, complement C3 of 0.468 g/L, complement C4 of 0.0107 g/L, and rheumatoid factor (RF) 678 IU/mL. The highest 24-hour urinary protein quantification reached 9.78 g/24h. After anti-infective treatment, urine output gradually increased, and edema resolved. Cryoglobulin testing showed type II cryoglobulin positivity. Light microscopy revealed MPGN-like lesions in 66.7% of glomeruli and mesangial proliferative glomerulonephritis-like lesions in 25%. Final diagnosis was MPGN. Cyclophosphamide and methylprednisolone were administered. After 30 months follow-up, the patient's serum creatinine level was 82.1 µmol/L; proteinuria was negative. Conclusion: This case represents the first reported instance of non-diffuse MPGN with cryoglobulinemic GN secondary to pSS. Infection may serve as a key factor in exacerbating cryoglobulinemia and triggering cryoglobulinemic GN onset.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.